Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3

Thomas J. van Rijssen, Elon H.C. van Dijk, Paula Scholz, Myrte B. Breukink, Rocio Blanco-Garavito, Eric H. Souied, Jan E.E. Keunen, Robert E. MacLaren, Giuseppe Querques, Sascha Fauser, Susan M. Downes, Carel B. Hoyng, Camiel J.F. Boon

Research output: Contribution to journalArticle

Abstract

Purpose: To compare the outcome between high-density subthreshold micropulse laser (HSML) treatment and half-dose photodynamic therapy (PDT) in chronic central serous chorioretinopathy (cCSC) patients, subdivided based on either focal or diffuse leakage on fluorescein angiography (FA). Design: Retrospective analysis of multicenter randomized controlled trial data. Methods: Patients were treated with either half-dose PDT or HSML (both indocyanine green angiography–guided) and categorized in 2 groups, based on focal or diffuse leakage on FA. Clinical outcomes were evaluated at baseline and during follow-up. Results: In the focal leakage group (63 patients), both at first evaluation and at final visit, more PDT-treated than HSML-treated patients demonstrated a resolution of subretinal fluid (evaluation visit 1: 57% in the PDT group and 17% in the HSML group, P =.007; final visit: 75% and 38%, P =.012). In the diffuse leakage group (93 patients), both at first evaluation and at final visit, more PDT-treated than HSML-treated patients showed a resolution of subretinal fluid (evaluation visit: 1:48% in the PDT group and 16% in the HSML group, P =.002; final visit: 67% and 21%, P =.002). PDT-treated patients in the focal and diffuse leakage group had a higher retinal sensitivity increase, comparing baseline and final visit (+3.1 ± 3.1 dB vs +1.2 ± 4.0 dB, P =.048, and +2.7 ± 3.3 dB vs +1.0 ± 3.8 dB, P =.036, respectively). Only in the diffuse leakage group, the increase in ETDRS letters was higher in the PDT-treated group when comparing baseline and first evaluation visit (+4.4 ± 6.1 vs +0.9 ± 10.0, P =.049). Conclusions: Half-dose PDT is superior to HSML treatment in cCSC patients, regardless of the presence of focal or diffuse leakage on FA.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalAmerican Journal of Ophthalmology
Volume205
DOIs
Publication statusPublished - Sep 2019

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3'. Together they form a unique fingerprint.

  • Cite this

    van Rijssen, T. J., van Dijk, E. H. C., Scholz, P., Breukink, M. B., Blanco-Garavito, R., Souied, E. H., Keunen, J. E. E., MacLaren, R. E., Querques, G., Fauser, S., Downes, S. M., Hoyng, C. B., & Boon, C. J. F. (2019). Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3. American Journal of Ophthalmology, 205, 1-10. https://doi.org/10.1016/j.ajo.2019.03.025